Research
Hormonal
GLP-1 receptor agonists can achieve weight loss of 15-17% with a good safety profile.
GLP-1 receptor agonists are a viable treatment option for weight loss in obese patients.
StrongSupportsmedium confidence
Los agonistas del receptor del péptido similar al glucagón-1 (AR GLP-1) logran pérdidas de peso del 15-17%, con un buen perfil de seguridad.
Why this rating
The claim is based on established data regarding GLP-1 receptor agonists.
Source
Weight management treatment in obesity
Miguel A. Rubio et al. · Medicina Clínica (English Edition) · 2025
review
Read the paper This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →